TG Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.

About TGTX

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.

CEO

Michael Sean Weiss

CEOMichael Sean Weiss

Employees

264

Employees264

Headquarters

Morrisville, North Carolina

HeadquartersMorrisville, North Carolina

Founded

1993

Founded1993

Employees

264

Employees264

TGTX Key Statistics

Market cap

2.13B

Market cap2.13B

Price-Earnings ratio

161.55

Price-Earnings ratio161.55

Dividend yield

—

Dividend yield—

Average volume

2.72M

Average volume2.72M

High today

$14.32

High today$14.32

Low today

$13.26

Low today$13.26

Open price

$13.87

Open price$13.87

Volume

3.65M

Volume3.65M

52 Week high

$35.67

52 Week high$35.67

52 Week low

$6.46

52 Week low$6.46

TGTX News

TipRanks 20h

TG Therapeutics announces additional data presentation for BRIUMVI - TipRanks.com - TipRanks

TG Therapeutics announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI in patients with relapsing forms of multi...

Simply Wall St 5d

TG Therapeutics shareholders are still up 78% over 5 years despite pulling back 5.4% in the past week - Simply Wall St

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But in our experience, buying the right stocks can give yo...

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

12.5%

Sell